At the same time, miR-132 showed neuroprotective effects by influencing ERK/MAPK1 activity, with the consequent reduction of both Aβ and Tau pathology hallmarks, as well as oxidative stress in AD animal models. Here, MAPK1 is linked to Alzheimer disease.